August 11, 2020
This morning medical device company Medtronic announced its plans to buy Companion Medical, which is best known for making the InPen, an insulin pen that integrates a companion app, for an undisclosed sum.
Companion Medical has been in the digital health game for some time. Its InPen fist scored FDA clearance in 2016 and its funding round attracted the likes of pharma giant Eli Lilly. The...
July 24, 2018
Putting yourself in someone else's shoes. High school students are learning about living with Alzheimer's disease in a new VR experience that simulates the experience for teens. The program, which was presented at the Alzheimer’s Association International Conference yesterday, has multiple different storylines for students to explore. The experience lets students see what it is like to live with...
October 21, 2016
Medtronic. Dexcom. Abbott. Sanofi. Google. A lot of very large, well-known companies are investing heavily into innovating the diabetes space, and that innovation is exciting. But a disproportionate amount of the innovation around insulin delivery focuses on the insulin pump, a delivery device that’s only used by a small percentage of insulin users. Most insulin users — between 70 and 93 percent...
October 7, 2016
As we take a look at the devices that received FDA clearance in 2016's third quarter, we're also considering that the last few months have been a time of change at the Food and Drug Administration, as regulators are beginning to make updates in their system to accomodate all the digital health tools we're seeing.
In June, the FDA offered up a draft guidance document designed to help medical...
July 28, 2016
Companion Medical, a stealthy San Diego-based company that received funding last year from Eli Lilly and Company, has received FDA 510(k) clearance for its Bluetooth-connected smart insulin pen and associated mobile app, called InPen.
"FDA clearance of the InPen and mobile app represents a significant advancement in diabetes care," CEO Sean Saint, a veteran engineer of Dexcom, Medtronic, and...
May 21, 2015
San Diego, California-based Companion Medical, a stealthy medical device startup developing a Bluetooth-connected insulin pen and connected app, has closed its second round of funding, led by Eli Lilly and Company. The funding amount was not disclosed.
Companion Medical previously raised $400,000 last year from Diamyd Medical, according to an SEC filing and a statement from the company. A...